Anavex Life Sciences: Weighing The Pros And Cons Of A Possible EU Approval ScenarioSeeking Alpha • 11/06/24
Anavex's Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer's Trial: Data Presented at CTAD Conference 2024GlobeNewsWire • 10/31/24
Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of SchizophreniaGlobeNewsWire • 10/17/24
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024GlobeNewsWire • 09/03/24
Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business UpdateGlobeNewsWire • 08/06/24
Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024GlobeNewsWire • 08/01/24
Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X ConferenceGlobeNewsWire • 07/30/24
Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association ConferenceGlobeNewsWire • 07/28/24
Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceGlobeNewsWire • 06/20/24
Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 05/15/24
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQGlobeNewsWire • 05/14/24
AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineAccesswire • 05/13/24
Anavex Life Sciences Corporation Class Action: Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXLAccesswire • 05/13/24
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $500,000 to Contact the FirmAccesswire • 05/13/24
Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class Action - AVXLAccesswire • 05/13/24
Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyAccesswire • 05/13/24
Investors who lost money on Anavex Life Sciences Corporation (AVXL) should contact Levi & Korsinsky about pending Class Action - AVXLAccesswire • 05/13/24
Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MorePRNewsWire • 05/13/24
Anavex Life Sciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AVXLAccesswire • 05/12/24
Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXLAccesswire • 05/12/24
Shareholders that lost money on Anavex Life Sciences Corporation (AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 05/10/24
Anavex Life Sciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXLAccesswire • 05/10/24
FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $500,000 to Contact the FirmAccesswire • 05/10/24